» Articles » PMID: 30298047

Differentiation of Brain Metastases and Gliomas Based on Color Map of Phase Difference Enhanced Imaging

Overview
Journal Front Neurol
Specialty Neurology
Date 2018 Oct 10
PMID 30298047
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Phase difference enhanced imaging (PADRE), a new phase-related MRI technique, can enhance both paramagnetic and diamagnetic substances, and select which phases to be enhanced. Utilizing these characteristics, we developed color map of PADRE (Color PADRE), which enables simultaneous visualization of myelin-rich structures and veins. Our aim was to determine whether Color PADRE is sufficient to delineate the characteristics of non-gadolinium-enhancing T2-hyperintense regions related with metastatic tumors (MTs), diffuse astrocytomas (DAs) and glioblastomas (GBs), and whether it can contribute to the differentiation of MTs from GBs. Color PADRE images of 11 patients with MTs, nine with DAs and 17 with GBs were created by combining tissue-enhanced, vessel-enhanced and magnitude images of PADRE, and then retrospectively reviewed. First, predominant visibility of superficial white matter and deep medullary veins within non-gadolinium-enhancing T2-hyperintense regions were compared among the three groups. Then, the discriminatory power to differentiate MTs from GBs was assessed using receiver operating characteristic analysis. The degree of visibility of superficial white matter was significantly better in MTs than in GBs ( = 0.017), better in GBs than in DAs ( = 0.014), and better in MTs than in DAs ( = 0.0021). On the contrary, the difference in the visibility of deep medullary veins was not significant ( = 0.065). The area under the receiver operating characteristic curve to discriminate MTs from GBs was 0.76 with a sensitivity of 80% and specificity of 64%. Visibility of superficial white matter on Color PADRE reflects inferred differences in the proportion of vasogenic edema and tumoral infiltration within non-gadolinium-enhancing T2-hyperintense regions of MTs, DAs and GBs. Evaluation of peritumoral areas on Color PADRE can help to distinguish MTs from GBs.

Citing Articles

Advances in the application of neuroinflammatory molecular imaging in brain malignancies.

Dong W, Wang N, Qi Z Front Immunol. 2023; 14:1211900.

PMID: 37533851 PMC: 10390727. DOI: 10.3389/fimmu.2023.1211900.


Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor.

Scola E, Del Vecchio G, Busto G, Bianchi A, Desideri I, Gadda D Cancers (Basel). 2023; 15(11).

PMID: 37296953 PMC: 10252005. DOI: 10.3390/cancers15112992.


Correlation between Phase-difference-enhanced MR Imaging and Amyloid Positron Emission Tomography: A Study on Alzheimer's Disease Patients and Normal Controls.

Takita H, Doishita S, Yoneda T, Tatekawa H, Abe T, Itoh Y Magn Reson Med Sci. 2022; 22(1):67-78.

PMID: 35082221 PMC: 9849423. DOI: 10.2463/mrms.mp.2021-0123.


Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches.

Roesler R, Dini S, Isolan G Clin Exp Immunol. 2021; 206(3):314-324.

PMID: 34591980 PMC: 8561695. DOI: 10.1111/cei.13668.


Differentiating Glioblastomas from Solitary Brain Metastases: An Update on the Current Literature of Advanced Imaging Modalities.

Fordham A, Hacherl C, Patel N, Jones K, Myers B, Abraham M Cancers (Basel). 2021; 13(12).

PMID: 34199151 PMC: 8231515. DOI: 10.3390/cancers13122960.


References
1.
Wesseling P, van der Laak J, Link M, Teepen H, Ruiter D . Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum Pathol. 1998; 29(4):352-8. DOI: 10.1016/s0046-8177(98)90115-0. View

2.
Ricci R, Bacci A, Tugnoli V, Battaglia S, Maffei M, Agati R . Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol. 2007; 28(7):1287-91. PMC: 7977674. DOI: 10.3174/ajnr.A0564. View

3.
Blasel S, Jurcoane A, Franz K, Morawe G, Pellikan S, Hattingen E . Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas. Acta Neurochir (Wien). 2010; 152(11):1893-9. DOI: 10.1007/s00701-010-0774-7. View

4.
Kim H, Jahng G, Ryu C, Kim S . Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol. 2009; 30(8):1574-9. PMC: 7051626. DOI: 10.3174/ajnr.A1635. View

5.
Kakeda S, Yoneda T, Ide S, Miyata M, Hashimoto T, Futatsuya K . Zebra sign of precentral gyri in amyotrophic lateral sclerosis: A novel finding using phase difference enhanced (PADRE) imaging-initial results. Eur Radiol. 2016; 26(11):4173-4183. DOI: 10.1007/s00330-016-4219-4. View